<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03558555</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 16-1763</org_study_id>
    <secondary_id>IF#16-1763</secondary_id>
    <secondary_id>IF#2175834</secondary_id>
    <nct_id>NCT03558555</nct_id>
  </id_info>
  <brief_title>Determine the Clinical Advantage of IV vs PO Acetaminophen</brief_title>
  <official_title>Comparative Efficacy of Intravenous Acetaminophen vs. Oral Acetaminophen in Ambulatory Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yan Lai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is limited research on the clinical outcome differences between intravenous (IV)
      acetaminophen versus oral (PO) acetaminophen. With the costs of intravenous acetaminophen
      sometimes being almost 100 times the cost of PO acetaminophen, it is not only important
      fiscally but also clinically to differentiate the benefits of IV vs PO acetaminophen. The
      proposed research study is to determine the clinical advantages of IV vs PO acetaminophen
      during the post-operative recovery time for ambulatory surgery patients by analyzing
      differences in time to first opioid delivery, pain scores, and patient satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In previous literature it has been shown that compared to placebo, IV acetaminophen can
      improve postoperative pain scores and reduce opioid requirements. In addition, IV
      acetaminophen has several pharmacokinetic properties that may be beneficial when compared to
      acetaminophen. IV acetaminophen has been shown to achieve a more rapid and higher maximum
      plasma concentration as well as higher cerebrospinal fluid concentrations. Comparative
      effectiveness trials of IV vs PO administration have not conclusively demonstrated improved
      clinical outcomes despite the proposed pharmacokinetic benefits. More research needs to be
      conducted to determine possible clinical advantages.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 8, 2017</start_date>
  <completion_date type="Actual">December 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants presenting for inguinal hernia surgery are assigned to either the oral or intravenous acetaminophen group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PACU Visual Analogue Pain Scores</measure>
    <time_frame>baseline, 1 hour, and Day 1 discharge</time_frame>
    <description>Post-Anesthesia Care Unity (PACU) pain scores at baseline, 1 hour, and on discharge from PACU. Pain score by visual analogue score, total scale from 0 to 10 with 10 being the worse pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total MME Intraoperatively</measure>
    <time_frame>Day 1</time_frame>
    <description>Total Morphine Milligram Equivalent (MME) use intraoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Narcotic Use in PACU.</measure>
    <time_frame>Day 1</time_frame>
    <description>Total narcotic use in PACU expressed in total morphine milligram equivalents (MME)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PACU Length of Stay</measure>
    <time_frame>up to 24 hours after PACU arrival</time_frame>
    <description>Time in PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Total Narcotic Use Post-discharge</measure>
    <time_frame>average 7 days</time_frame>
    <description>home opiod use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction.</measure>
    <time_frame>7 days post surgery</time_frame>
    <description>Patient satisfaction total scale from 1 to 10, with higher score indicating more satisfaction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>Oral Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who are randomized to have oral acetaminophen will take oral acetaminophen preoperatively and receive saline intraoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen IV Soln</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to IV acetaminophen will receive IV acetaminophen after induction of general anesthesia and will take placebo pills preoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen IV Soln</intervention_name>
    <description>1000mg of IV acetaminophen</description>
    <arm_group_label>Acetaminophen IV Soln</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Acetaminophen</intervention_name>
    <description>oral acetaminophen 975mg pills</description>
    <arm_group_label>Oral Acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Pills</intervention_name>
    <description>placebo match to acetaminophen</description>
    <arm_group_label>Acetaminophen IV Soln</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Intravenous saline</description>
    <arm_group_label>Oral Acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA scores I-III

          -  Ambulatory surgery patients

          -  Ages 18-75

          -  Surgeries requiring general anesthesia for hernia surgery

        Exclusion Criteria:

          -  Patients with contraindications to acetaminophen (history of end organ liver
             dysfunction)

          -  Known allergy to acetaminophen

          -  Emergency surgery

          -  Patients who were not fasted

          -  Patients who cannot tolerate PO

          -  Surgery anticipated to last longer than 3 hours or requiring re-dose of acetaminophen

          -  Pregnancy

          -  Weight less than 50kg

          -  Chronic daily narcotic use

          -  Patients who's anesthetic plan requires regional anesthesia

          -  Patient refusal to participate or do not have capacity to provide consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Lai, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai West Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Helander EM, Webb MP, Bias M, Whang EE, Kaye AD, Urman RD. A Comparison of Multimodal Analgesic Approaches in Institutional Enhanced Recovery After Surgery Protocols for Colorectal Surgery: Pharmacological Agents. J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):903-908. doi: 10.1089/lap.2017.0338. Epub 2017 Jul 25.</citation>
    <PMID>28742427</PMID>
  </reference>
  <reference>
    <citation>Moller PL, Sindet-Pedersen S, Petersen CT, Juhl GI, Dillenschneider A, Skoglund LA. Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery. Br J Anaesth. 2005 May;94(5):642-8. Epub 2005 Mar 24.</citation>
    <PMID>15790675</PMID>
  </reference>
  <reference>
    <citation>Olbrecht VA, Ding L, Spruance K, Hossain M, Sadhasivam S, Chidambaran V. Intravenous Acetaminophen Reduces Length of Stay Via Mediation of Postoperative Opioid Consumption After Posterior Spinal Fusion in a Pediatric Cohort. Clin J Pain. 2018 Jul;34(7):593-599. doi: 10.1097/AJP.0000000000000576.</citation>
    <PMID>29200016</PMID>
  </reference>
  <results_reference>
    <citation>Patel A, Pai B H P, Diskina D, Reardon B, Lai YH. Comparison of clinical outcomes of acetaminophen IV vs PO in the peri-operative setting for laparoscopic inguinal hernia repair surgeries: A triple-blinded, randomized controlled trial. J Clin Anesth. 2020 May;61:109628. doi: 10.1016/j.jclinane.2019.109628. Epub 2019 Oct 25.</citation>
    <PMID>31669049</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <results_first_submitted>December 31, 2019</results_first_submitted>
  <results_first_submitted_qc>January 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 10, 2020</results_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Yan Lai</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology, Perioperative &amp; Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>Acetaminophen</keyword>
  <keyword>Tylenol</keyword>
  <keyword>Intravenous versus oral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 2, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/55/NCT03558555/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants presenting for laparoscopic hernia repair under general anesthesia in an ambulatory setting were recruited from July 2017 to December 2018. First enrollment in Dec 2017.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Oral Acetaminophen</title>
          <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
        </group>
        <group group_id="P2">
          <title>Acetaminophen IV Soln</title>
          <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oral Acetaminophen</title>
          <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
        </group>
        <group group_id="B2">
          <title>Acetaminophen IV Soln</title>
          <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="56"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.93" spread="13.37"/>
                    <measurement group_id="B2" value="52.52" spread="15.10"/>
                    <measurement group_id="B3" value="53.31" spread="14.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="56"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>PACU Visual Analogue Pain Scores</title>
        <description>Post-Anesthesia Care Unity (PACU) pain scores at baseline, 1 hour, and on discharge from PACU. Pain score by visual analogue score, total scale from 0 to 10 with 10 being the worse pain.</description>
        <time_frame>baseline, 1 hour, and Day 1 discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>PACU Visual Analogue Pain Scores</title>
          <description>Post-Anesthesia Care Unity (PACU) pain scores at baseline, 1 hour, and on discharge from PACU. Pain score by visual analogue score, total scale from 0 to 10 with 10 being the worse pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="2.72"/>
                    <measurement group_id="O2" value="1.52" spread="2.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.88" spread="2.74"/>
                    <measurement group_id="O2" value="2.41" spread="2.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge from PACU, up to 2.5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" spread="1.51"/>
                    <measurement group_id="O2" value="1.59" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.82" spread="2.28"/>
                    <measurement group_id="O2" value="4.27" spread="1.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.64" spread="2.26"/>
                    <measurement group_id="O2" value="4.16" spread="1.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total MME Intraoperatively</title>
        <description>Total Morphine Milligram Equivalent (MME) use intraoperatively</description>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Total MME Intraoperatively</title>
          <description>Total Morphine Milligram Equivalent (MME) use intraoperatively</description>
          <units>MME</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.75" spread="21.33"/>
                    <measurement group_id="O2" value="57.24" spread="29.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Narcotic Use in PACU.</title>
        <description>Total narcotic use in PACU expressed in total morphine milligram equivalents (MME)</description>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Total Narcotic Use in PACU.</title>
          <description>Total narcotic use in PACU expressed in total morphine milligram equivalents (MME)</description>
          <units>MME</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.33" spread="17.10"/>
                    <measurement group_id="O2" value="9.83" spread="11.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PACU Length of Stay</title>
        <description>Time in PACU</description>
        <time_frame>up to 24 hours after PACU arrival</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>PACU Length of Stay</title>
          <description>Time in PACU</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.93" spread="55.79"/>
                    <measurement group_id="O2" value="64.05" spread="33.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Total Narcotic Use Post-discharge</title>
        <description>home opiod use</description>
        <time_frame>average 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Total Narcotic Use Post-discharge</title>
          <description>home opiod use</description>
          <units>MME</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.06" spread="14.02"/>
                    <measurement group_id="O2" value="17.56" spread="17.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction.</title>
        <description>Patient satisfaction total scale from 1 to 10, with higher score indicating more satisfaction</description>
        <time_frame>7 days post surgery</time_frame>
        <population>one missing survey</population>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen IV Soln</title>
            <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction.</title>
          <description>Patient satisfaction total scale from 1 to 10, with higher score indicating more satisfaction</description>
          <population>one missing survey</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.05" spread="2.18"/>
                    <measurement group_id="O2" value="6.20" spread="3.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Oral Acetaminophen</title>
          <description>Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.</description>
        </group>
        <group group_id="E2">
          <title>Acetaminophen IV Soln</title>
          <description>Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alopi Patel</name_or_title>
      <organization>Icahn School of Medicine at Mount Sinai</organization>
      <phone>(212) 523-6357</phone>
      <email>Alopi.patel@mountsinai.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

